Mapping Multidimensional Illness Trajectories of Patients With End-stage Kidney Disease
1 other identifier
observational
227
1 country
1
Brief Summary
Patients with end-stage kidney disease (ESKD) must manage not only the demands of dialysis and comorbid conditions but also associated symptoms and acute life-threatening events that contribute to functional limitations and increased risk of mortality. Yet little is known about the trajectories of quality of life dimensions in patients with ESKD when they experience acute life-threatening episodes, to guide palliative care for this population. In this prospective, descriptive study, we will identify trajectories of symptoms, physical functioning, psychosocial needs, and emotional and spiritual well-being in 200 patients with ESKD who are at a high risk of experiencing acute life-threatening events and mortality within 12 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2012
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 7, 2012
CompletedFirst Posted
Study publicly available on registry
February 10, 2012
CompletedStudy Start
First participant enrolled
March 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2015
CompletedSeptember 4, 2015
September 1, 2015
3.3 years
February 7, 2012
September 2, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Symptoms, physical functioning, psychosocial needs, spiritual well-being, cognitive functioning
12 months
Eligibility Criteria
ESKD patients who have been on dialysis
You may qualify if:
- aged 18 years or older;
- receiving either Hemodialysis or Peritoneal dialysis
- on dialysis either \< 3 months or ≥ 6 months with a Charlson Comorbidity Index (CCI) score ≥ 5
You may not qualify if:
- Patients who are enrolled in hospice or too sick to participate in questionnaire completion will not be eligible.
- Kidney transplant candidates will be excluded because their illness trajectories after transplant are likely to differ.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UNC Hospitals and outpatient dialysis clinics
Chapel Hill, North Carolina, 27514, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mi-Kyung Song, PhD, RN, FAAN
University of North Carolina, Chapel Hill
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 7, 2012
First Posted
February 10, 2012
Study Start
March 1, 2012
Primary Completion
July 1, 2015
Study Completion
July 1, 2015
Last Updated
September 4, 2015
Record last verified: 2015-09